118 related articles for article (PubMed ID: 7734150)
1. Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupole.
Moore GJ; Ganter RC; Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Wilkinson S; Sandall J; Fowler P
J Mol Recognit; 1994 Dec; 7(4):251-6. PubMed ID: 7734150
[TBL] [Abstract][Full Text] [Related]
2. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
Moore GJ; Ganter RC; Goghari MH; Franklin KJ
Int J Pept Protein Res; 1991 Jul; 38(1):1-7. PubMed ID: 1938100
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophan.
Matsoukas JM; Goghari MH; Scanlon MN; Franklin KJ; Moore GJ
J Med Chem; 1985 Jun; 28(6):780-3. PubMed ID: 4009600
[TBL] [Abstract][Full Text] [Related]
4. Differences in backbone structure between angiotensin II agonists and type I antagonists.
Matsoukas JM; Agelis G; Wahhab A; Hondrelis J; Panagiotopoulos D; Yamdagni R; Wu Q; Mavromoustakos T; Maia HL; Ganter R
J Med Chem; 1995 Nov; 38(23):4660-9. PubMed ID: 7473593
[TBL] [Abstract][Full Text] [Related]
5. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanine.
Hondrelis J; Matsoukas J; Cordopatis P; Ganter RC; Franklin KJ; Moore GJ
Int J Pept Protein Res; 1991 Jan; 37(1):21-6. PubMed ID: 2045217
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
[TBL] [Abstract][Full Text] [Related]
8. Topographic probes of angiotensin and receptor: potent angiotensin II agonist containing diphenylalanine and long-acting antagonists containing biphenylalanine and 2-indan amino acid in position 8.
Hsieh KH; LaHann TR; Speth RC
J Med Chem; 1989 Apr; 32(4):898-903. PubMed ID: 2704034
[TBL] [Abstract][Full Text] [Related]
9. 1H-NMR studies of [Sar1]angiotensin II conformation by nuclear Overhauser effect spectroscopy in the rotating frame (ROESY): clustering of the aromatic rings in dimethylsulfoxide.
Matsoukas JM; Bigam G; Zhou N; Moore GJ
Peptides; 1990; 11(2):359-66. PubMed ID: 2356159
[TBL] [Abstract][Full Text] [Related]
10. Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.
Matsoukas JM; Hondrelis J; Keramida M; Mavromoustakos T; Makriyannis A; Yamdagni R; Wu Q; Moore GJ
J Biol Chem; 1994 Feb; 269(7):5303-12. PubMed ID: 8106515
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence properties of angiotensin II analogues in receptor-simulating environments: relationship between tyrosinate fluorescence lifetime and biological activity.
Turner RJ; Matsoukas JM; Moore GJ
Biochim Biophys Acta; 1991 May; 1065(1):21-8. PubMed ID: 2043649
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Goghari MH; Franklin KJ; Moore GJ
J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
[TBL] [Abstract][Full Text] [Related]
13. The role of position 4 in angiotensin II antagonism: a structure-activity study.
Samanen J; Cash T; Narindray D; Brandeis E; Yellin T; Regoli D
J Med Chem; 1989 Jun; 32(6):1366-70. PubMed ID: 2724307
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal modulation of the binding of angiotensin agonists and antagonists to angiotensin receptors in smooth muscle.
Koziarz P; Beck J; Moore GJ
Gen Pharmacol; 1993 May; 24(3):705-13. PubMed ID: 8365653
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin analogues palmitoylated in positions 1 and 4.
Maletínská L; Neugebauer W; Pérodin J; Lefebvre M; Escher E
J Med Chem; 1997 Sep; 40(20):3271-9. PubMed ID: 9379447
[TBL] [Abstract][Full Text] [Related]
17. Structure-function analyses of brain angiotensin control of pressor action in rats.
Wright JW; Jensen LL; Roberts KA; Sardinia MF; Harding JW
Am J Physiol; 1989 Dec; 257(6 Pt 2):R1551-7. PubMed ID: 2604011
[TBL] [Abstract][Full Text] [Related]
18. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction.
Noda K; Feng YH; Liu XP; Saad Y; Husain A; Karnik SS
Biochemistry; 1996 Dec; 35(51):16435-42. PubMed ID: 8987975
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiotensinogen production by angiotensin II analogues in human hepatoma cell line.
Coezy E; Darby I; Mizrahi J; Cantau B; Donnadieu MH; Nussberger J; Escher E; Chapnick B; Corvol P
Am J Physiol; 1989 Nov; 257(5 Pt 1):C888-95. PubMed ID: 2596583
[TBL] [Abstract][Full Text] [Related]
20. [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells.
Aceto JF; Baker KM
Am J Physiol; 1990 Mar; 258(3 Pt 2):H806-13. PubMed ID: 1690518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
